COMMUNIQUÉS West-GlobeNewswire

High Hampton Expands Strategic Network in California -- CFN Media

25/06/2018 - 14:47

SEATTLE, June 25, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication of an article [...]

ORYZON announces First Patients in the UK in ETHERAL: a Phase IIa clinical trial in Alzheimer’s Disease with ORY-2001

25/06/2018 - 14:35

MADRID, Spain and CAMBRIDGE, Mass., June 25, 2018 (GLOBE NEWSWIRE) -- Oryzon Genomics (ISIN Code:ES0167733015) (BME:ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in [...]

Marrone Bio Innovations Joins the Russell 2000 Index

25/06/2018 - 14:31

DAVIS, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ:MBII) (MBI), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and [...]

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

25/06/2018 - 14:30

FIT Biotech Oy Company release June 25, 2018 at 03:30 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on December 22, 2017 [...]

Vericel Added to Russell 3000® Index

25/06/2018 - 14:30

CAMBRIDGE, Mass., June 25, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced that it has been added to [...]

International Endeavors to Open Showroom in Las Vegas

25/06/2018 - 14:30

TEMECULA, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Plans are underway for International Endeavors Corporation (OTC: IDVV) to open a showroom in Las Vegas to demonstrate the Off Grid Grow Laboratory ( [...]

Albireo Added to Russell 2000® Index

25/06/2018 - 14:30

BOSTON, June 25, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that it has been added to the [...]

Peer Reviewed Results: Conformis Patient Specific iTotal CR Achieves Better Rotational Alignment and Tibial Fit Compared to Off-the-Shelf Implants

25/06/2018 - 14:30

Manuscript highlights the intraoperative compromises of fit vs. rotation with the legacy off-the-shelf knee implants BILLERICA, Mass., June 25, 2018 (GLOBE NEWSWIRE) -- Conformis Inc. (NASDAQ:CFMS), a medical technology [...]

Portola Pharmaceuticals Appoints 30-Year Industry Veteran Glenn Brame as Senior Vice President of Technical Operations

25/06/2018 - 14:30

SOUTH SAN FRANCISCO, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq:PTLA) today announced the appointment of Glenn Brame as senior vice president of technical operations, effective [...]

Progenics Pharmaceuticals Presents Data Validating its Artificial Intelligence Imaging Analysis Technology for Use with PSMA-Targeted SPECT/CT

25/06/2018 - 14:30

Algorithm Validated Using Data from Company's 1404 Phase 2 Study NEW YORK, June 25, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative medicines and imaging [...]

Catalyst Biosciences Joins the Russell 2000® Index

25/06/2018 - 14:30

SOUTH SAN FRANCISCO, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ:CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications [...]

Biomerica Announces First Patient Enrollment in Clinical Study for New Irritable Bowel Syndrome (IBS) Diagnostic Guided Therapy

25/06/2018 - 14:19

Diagnostic Guided Therapy (DGT) is designed to identify patient specific foods, that when removed, may alleviate an individual's IBS symptoms Approximately 45 million Americans suffer from IBS 1 Studies being conducted [...]

GTX Corp Announces Strategic Plan to Up-List to the OTCQB Venture Exchange

25/06/2018 - 14:14

LOS ANGELES, June 25, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB: GTXO) (“the Company”) , a pioneer in the field of wearable GPS human and asset tracking systems and wandering assistive technology, announced today it has [...]

Avid Bioservices Added to Russell 3000® Index and Russell 2000® Index

25/06/2018 - 14:05

TUSTIN, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by [...]

Nuvectra Added to the Russell 2000® Index

25/06/2018 - 14:01

PLANO, Texas, June 25, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that it was added to the Russell 2000 ® Index when Russell Investments [...]

Endocyte to Join the Russell 3000® Index

25/06/2018 - 14:01

WEST LAFAYETTE, Ind., June 25, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced that its common stock [...]

Savara Joins Russell 3000® Index

25/06/2018 - 14:00

AUSTIN, Texas, June 25, 2018 (GLOBE NEWSWIRE) -- Savara Inc. (NASDAQ:SVRA), an orphan lung disease company, announced today that the company has been added to the broad-market Russell 3000 Index. “In the little more [...]

BIOLIFE4D Successfully Demonstrates Ability to 3D Bioprint Human Cardiac Tissue

25/06/2018 - 14:00

Pioneering biotech company reaches significant milestone well ahead of 6-8 month development time, successfully 3D bioprinting a human cardiac patch, as it seeks to produce full human hearts viable for transplant [...]

Atara Biotherapeutics Opens State-of-the-Art Operations and Manufacturing Facility to Support Robust Off-the-Shelf T-Cell Immunotherapy Pipeline

25/06/2018 - 14:00

SOUTH SAN FRANCISCO, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]